| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5f6113bfdb20e0b6d777bf559eb4b70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffb8b6f30dafe5d3264afb51d9f9aedf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6310f8c62ffbb84cd17ca210f64ec82c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94432edddf4c5c4632e94216b0daf3ea |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 |
| filingDate |
2001-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e218e9200939984b99fef5d5799ac6b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a22ea5145fa91ca2769d97f6a7852b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ceae9c93fd04c3a92c822566ed97da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41cd9a4aaa0f5b559d1acb792f5553bc |
| publicationDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2190404-C1 |
| titleOfInvention |
Preparation for treatment of obliterating atherosclerosis of lower limb vessels and method for its treatment |
| abstract |
FIELD: medicine. SUBSTANCE: one should additionally inject 2-ethyl-6-methyl-3-oxypyridine succinate for 10 d at the dosage of 400 mg/d: intravenously twice daily at the dosage of 200 ml 0.9%- sodium chloride. The method correlates the main pathogenic links of the disease. EFFECT: higher efficiency of therapy. 1 cl, 2 ex, 4 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014012593-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101903352-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009078746-A1 |
| priorityDate |
2001-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |